Disconcordance between different molecular methods to assess homozygous deletion of the CDKN2A/B locus in IDH-mutant astrocytomas

Autor: Vallentgoed, W., van Dijk, E., van den Bent, M. J., Draaisma, K., van Eijk, P., van Garderen, K., de Heer, I, Hoogstrate, Y., Kouwenhoven, M., Kros, J. M., de Leng, W., van Nee, M., Niers, A., Robe, P., Smits, M., Westerman, B., van de Wiel, M., Ylstra, B., Wesseling, P., French, P. J.

Publikováno v: Vallentgoed, W, van Dijk, E, van den Bent, M J, Draaisma, K, van Eijk, P, van Garderen, K, de Heer, I, Hoogstrate, Y, Kouwenhoven, M, Kros, J M, de Leng, W, van Nee, M, Niers, A, Robe, P, Smits, M, Westerman, B, van de Wiel, M, Ylstra, B, Wesseling, P & French, P J 2022, ' Disconcordance between different molecular methods to assess homozygous deletion of the CDKN2A/B locus in IDH-mutant astrocytomas ', Neuro-Oncology, vol. 24 . https://doi.org/10.1093/neuonc/noac174.123
Neuro-Oncology, 24. Oxford University Press

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2a2a0f16dd58a2cd23271ae502fa3e5b
https://research.vumc.nl/en/publications/5fbaf8fa-f9e6-436d-baa5-b002e279aebe

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

Autor: Komor, MA, Wit, M, Berg, J, de Kemp, SRM, Delis-van Diemen, PM, Bolijn, AS, Tijssen, M, Schelfhorst, T, Piersma, SR, Chiasserini, D, Sanders, J, Rausch, C, Hoogstrate, Youri, Stubbs, Andrew, Jong, M, Jenster, Guido, Carvalho, B, Meijer, GA, Jimenez, CR, Fijneman, RJA, Dits, Natasja, Böttcher, René, Hiemstra, AC, Ylstra, B, Sie, D, Broek, E, van Grieken, N, Meer, D, Pepers, F, Caldenhoven, E, Janssen, B, van Workum, W, van Lieshout, S, Bangma, C.H., van Leenders, Arno, van de Werken, Harmen

Publikováno v: International Journal of Cancer, 146(7), 1979-1992. Wiley-Liss Inc.
Komor, M A, de Wit, M, van den Berg, J, Martens de Kemp, S R, Delis-van Diemen, P M, Bolijn, A S, Tijssen, M, Schelfhorst, T, Piersma, S R, Chiasserini, D, Sanders, J, Rausch, C, Hoogstrate, Y, Stubbs, A P, de Jong, M, Jenster, G, Carvalho, B, Meijer, G A, Jimenez, C R, Fijneman, R J A & In collaboration with the NGS-ProToCol Consortium 2020, ' Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression ', International Journal of Cancer, vol. 146, no. 7, pp. 1979-1992 . https://doi.org/10.1002/ijc.32627
International Journal of Cancer

Removal of colorectal adenomas is an effective strategy to reduce colorectal cancer (CRC) mortality rates. However, as only a minority of adenomas progress to cancer, such strategies may lead to overtreatment. The present study aimed to characterize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0f18edb5b8a61777493b094f6c33b9d
https://doi.org/10.1002/ijc.32627

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer

Autor: Postma, C., Koopman, M., Buffart, T.E., Eijk, P.P., Carvalho, B., Peters, G.J., Ylstra, B., van Krieken, J.H., Punt, C.J.A., Meijer, G.A. ^*

Publikováno v: In Annals of Oncology June 2009 20(6):1048-1056

S02. TUMOUR RISKS AND GENOTYPE-PHENOTYPE ANALYSIS IN AN IRISH COHORT OF PATIENTS WITH GERMLINE MUTATIONS IN THE SUCCINATE DEHYDROGENASE SUBUNIT GENES SDHB, SDHC AND SDHD

Autor: Hynds, P, Coghlan, D, Purcell, C, Green, A, Ward, A, Lynch, SA, Hough, O, Duff, M, Cody, N, Carroll, C, Bradley, L, Green, Andrew, Lynch, Sally-Ann, Crushell, E, Byrne, N, Gorman, K, King, M, Irvine, A, Monavari, A, Knerr, I, Cotter, M, McConnell, V, Browne, F, Lambert, D, Turner, J, Casey, J, Doyle, S, Nesbitt, IM, Fitzgibbon, M, Pastores, G, Kirk, R, Treacy, EP, Benson, KA, Kennedy, C, Yachnin, K, Cavalleri, G L, Conlon, P, McVeigh, Úna M, McVeigh, Terri P, Miller, Nicola, Morris, Derek W, Kerin, Michael J, Irwin, R., Caffrey, A., McLaughlin, M., McNulty, H., Cassidy, T., Pentieva, K., Walsh, C., Minguzzi, S, MacCooey, A, Brosnan, J, Brosnan, M, Henry, M, Meleady, P, Parle-McDermott, A, Gilbert, EH, O’Reilly, S, Merrigan, M, McGettigan, D, Molloy, AM, Brody, LC, Bodmer, W, Hutnik, K, Ennis, S, Lawson, DJ, Wilson, JF, Cavalleri, GL, Flynn, M, Whitton, L, Gill, M, Corvin, A, Donohoe, G, Morrison, C, Morris, D, Stapleton, CP., Birdwell, KA., Mark, PB., Sanders, ML., Phelan, PJ., Maxwell, AP., McKnight, AJ., Kennedy, C., Jardine, A., Traynor, J.P, Chapman, F., Keating, B., Conlon, PJ., Cavalleri, GL., Gunne, EA, Lambert, DM, Martin, R, Donnelly, DE, Callaghan, MB, Morrison, PJ, McConville, DO, Archbold, GP, Lewis, A, Morrison, P J, Das, S., Kelly, D., Moran, B., Harold, E., Han, K., Mulligan, N., Barrett, C., Buckley, P.G., Mc Mahon, P., McCaffrey, J, Van Essen, H. F., Connor, K., Ylstra, B., Lambrechts, D., Gallagher, W.M., O’Connor, D.P., Kelly, C.M., O’Neill, T, Power, C, de Franco, E, Ellard, S, Antao, B, O’Connell, SM, Dabir, T, Heggarty, S, Dockery, A, Carrigan, M, Wynne, N, Keegan, D, Stevenson, K, Silvestri, G, McCourt, J, Humphries, P, Kenna, PF., Farrar, GJ, Agbahovbe, R, Cohen, ASA, Gibson, WT, Cole, AM, Bohlender, R., Hu, H, Heinrich, E, Ramirez, C, Yu, Y, Powell, F, Gaio, E, Villafuerte, F., Taylor, C, Huff, C, Simonson, T., Cavalleri, G., Scullion, C, Irwin, R, Thakur, A, Walsh, C, Shortall, C, Palfi, A, Chadderton, N, Kenna, PF, Boomkamp, S, Shen, S, Hardcastle, AJ, Maloney, DM, Millington-Ward, S, Mackin, S-J, Irwin, R E., O’Neill, KM., Pollin, G, Apostolova, G, Dechant, G, Mackin, SJ, O’Neill, K, Walsh, CP, Sohedein, MNA, Morris, DW, Chaudhry, M, Segurado, R, Shields, D, Wilson, AG, Watkin, R.L., Piskareva, O., Madden, S., Stallings, R., Kerrigan, S.W., O’Neill, K M., Thursby, SJ, Bertens, C, Masala, L, Loughery, J, McArt, D, Amenyah, S. D., McMahon, A., Deane, J., Ward, M., Strain, J.J., Horigan, G., Purvis, J., Lees-Murdock, D., Lynch, SM., Ward, M, McNulty, H, Horigan, G, Purvis, J, Tackett, M, McKenna, DJ., Angel, Z, Walsh, CP.

Publikováno v: The Ulster Medical Journal

Neurofibromatosis (NF1) affects 1/2500 people throughout the world. Children with NF1 require a multidisciplinary service ideally, delivered on a single site. NF1 is a very variable condition with children requiring the expertise of genetics, paediat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmc_________::fdf6c40aeeb2ef81cbaee6c14650e042
http://europepmc.org/articles/PMC5849961